Blogs & Articles

Signals One unifies and structures data to be AI-ready. Our automation allows AI and machine-learning tools analyze data so that scientists can focus on innovation.

Modern drug discovery and biosimilar development projects generate very large volumes of data, yet results held in proprietary, legacy and device-dependent unstructured formats can limit access and lead to increased costs and lengthened delays. Help is at hand, with new AI solutions able to find, process, and summarize data from almost any source in near-real-time, transforming productivity.

This article discusses how integrating technologies like AI, machine learning, and data analytics can enhance drug development efficiency in India's pharmaceutical industry.

This article explores the adoption of Electronic Lab Notebooks (ELNs) in India's pharmaceutical sector, emphasizing their role in enhancing research efficiency, collaboration, and compliance.

This article highlights how Electronic Lab Notebooks (ELNs) are transforming research workflows in India's life sciences sector.

This article highlights the growing adoption of Electronic Lab Notebooks (ELNs) in India's pharmaceutical sector to improve research efficiency, compliance, and innovation.

This article discusses how the chemical industry in India is embracing digital technologies like Electronic Lab Notebooks (ELNs) to streamline R&D workflows, improve data management, and enhance regulatory compliance.

Pharmaceutical and biotechnology companies face many changes if the Biosecure Act passes into law. Learn how Revvity Signals solutions, such as Signals Synergy can aid the biotechnology sector.

Revvity Signals was first-to-market with SaaS software and integrates AI to help empower scientists. Read our interview with David Gosalvez to learn the future vision of Revvity Signals.

In 2024, Signals ChemDraw, Signals Clinical and Signals Synergy launched. Read how Revvity Signals supports new modalities in drug discovery and research development.

Revvity Signals handles all software development, allowing researchers to explore new drug therapies. Learn how our cloud-native software helps with performance, cost and scalability.

Artificial intelligence (AI) and machine learning (ML) are revolutionizing the cybersecurity space. Learn how Revvity Signals uses AI and other techniques to protect data.